Gotoh, Momokazu

Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study

Kobayashi, T., Iwama, S., Yasuda, Y., Okada, N., Tsunekawa, T., Onoue, T., Takagi, H., Hagiwara, D., Ito, Y., Morishita, Y., et al. (2018) · Journal of the Endocrine Society

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 203

Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study

Okada, N., Iwama, S., Okuji, T., Kobayashi, T., Yasuda, Y., Wada, E., Onoue, T., Goto, M., Sugiyama, M., Tsunekawa, T., et al. (2020) · British Journal of Cancer

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 78

Clinical guideline for female lower urinary tract symptoms

TAKAHASHI, S., TAKEI, M., NISHIZAWA, O., YAMAGUCHI, O., KATO, K., GOTOH, M., YOSHIMURA, Y., TAKEYAMA, M., OZAWA, H., SHIMADA, M., et al. (2016) · LUTS: Lower Urinary Tract Symptoms

Urinary Bladder and Prostate ResearchPelvic floor disorders treatments

Cited by 47

Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patients

Inoue, S., Sassa, N., Kato, T., Yamauchi, Y., Hirabayashi, T., Yuguchi, Y., Maeda, M., Soeda, Y., Hattori, R., & Gotoh, M. (2020) · International Journal of Urology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 11